Neola Medical AB

As of June 30, 2026, Neola Medical AB carries a market capitalization of 68.21M, placing it among publicly traded companies globally. Its enterprise value stands at 64.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Neola Medical AB's next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, Neola Medical AB has 77.95M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Neola Medical AB maintains a current ratio of 5.42, meaning it holds 5.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Neola Medical AB posted a negative return on equity (ROE) of -14.20, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -13.39, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 4.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Neola Medical AB's stock has declined approximately 73.09% over the past 52 weeks. The 50-day moving average sits at 0.51, while the 200-day moving average is 0.79.

Over the twelve months ended June 30, 2026, Neola Medical AB generated - - in revenue and converted that into -12.70M in net income, yielding earnings per share of -0.16. EBITDA reached -11.27M, while operating income came in at -12.67M.

These figures are as of June 30, 2026. Total book value stands at 97.59M, with working capital of 30.30M providing operational flexibility.

Neola Medical AB produced -11.66M in operating cash flow over the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -16.65: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches - -, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Neola Medical AB shareholders.

Neola Medical AB's most recent stock split took place on May 29, 2026 with a 85:88 split ratio.